It is widely accepted that abnormal forms of the prion protein (PrP) are the best surrogate marker for the infectious agent of prion diseases and, in practice, the detection of such diseaseassociated (PrP d ) and/or protease-resistant (PrP res ) forms of PrP is the cornerstone of diagnosis and surveillance of the transmissible spongiform encephalopathies (TSEs). Nevertheless, some studies question the consistent association between infectivity and abnormal PrP detection. To address this discrepancy, 11 brain samples of sheep affected with natural scrapie or experimental bovine spongiform encephalopathy were selected on the basis of the magnitude and predominant types of PrP d accumulation, as shown by immunohistochemical (IHC) examination; contra-lateral hemi-brain samples were inoculated at three different dilutions into transgenic mice overexpressing ovine PrP and were also subjected to quantitative analysis by three biochemical tests (BCTs). Six samples gave 'low' infectious titres (10 6.5 to 10 6.7 LD 50 g "1
) and five gave 'high titres' (10 8.1 to ¢10 8.7 LD 50 g "1 ) and, with the exception of the Western blot analysis, those two groups tended to correspond with samples with lower PrP d /PrP res results by IHC/BCTs.
However, no statistical association could be confirmed due to high individual sample variability. It is concluded that although detection of abnormal forms of PrP by laboratory methods remains useful to confirm TSE infection, infectivity titres cannot be predicted from quantitative test results, at least for the TSE sources and host PRNP genotypes used in this study. Furthermore, the near inverse correlation between infectious titres and Western blot results (high protease pretreatment) argues for a dissociation between infectivity and PrP res .
INTRODUCTION
The detection of abnormal prion protein (PrP) accumulating in the brains of infected animals is the basis of the diagnostic tests for prion diseases or transmissible spongiform encephalopathies (TSEs). Whether by visualization of disease-associated PrP (PrP d , also designated PrP Sc ) aggregates by immunohistochemistry (IHC) or by detection of proteinase K (PK)-resistant PrP (PrP res ) by biochemical tests (BCTs), demonstrating the presence of abnormal PrP remains the cornerstone of TSE diagnosis, and PrP d /PrP res is widely considered a surrogate marker of the infectious agent(s). However, early evidence from a variety of experiments (reviewed by Rohwer, 1991) suggests that relationships between infectivity and positive test results for PrP d /PrP res are not simple. More recently, in certain TSE models where infectivity has been demonstrated, little or no PrP res can be detected by conventional laboratory methods (Lasmezas et al., 1997; Barron & Manson, 2003; Barron et al., 2007; Balkema-Buschmann et al., 2011) , while in other models the magnitude of PrP d revealed by IHC or histoblotting lacks correlation with infectivity (Jeffrey et al., 2001a) . Such studies suggest the existence of infectious and pathological conformations of PrP that are not readily detectable by current diagnostic tests. Conversely, not all PrP d /PrP res forms that are detected by laboratory tests methods may necessarily be infectious (Piccardo et al., 2007; Jeffrey et al., 2012) , and dissociation between abundance of PrP res and infectivity has also been reported as one of the arguments against the prion hypothesis (Miyazawa et al., 2011) .
Determining the association or dissociation between the TSE infectious agent(s) and its surrogate markers is of importance in terms of possible underdiagnosis, not only at the level of the animal but also in the identification of tissues that contain infectivity. Such determination is therefore of relevance for food safety, animal health and disease eradication policies.
In previous studies we have shown that, depending on the TSE strain and model, sheep diagnosed with clinical disease display different patterns of deposition of PrP d in the brain as demonstrated by IHC. For example, in the brains of CH1641 experimentally infected sheep, PrP d deposits are almost exclusively found within the cytoplasm of neurons and microglial cells (Jeffrey et al., 2006) , while in a model of natural scrapie in Suffolk sheep, the majority of PrP d is extracellular and predominantly associated with astrocytes (González et al., 2002 (González et al., , 2003 (González et al., , 2010b Sisó et al., 2010) ; by ultrastructural examination such extracellular PrP d is shown to aggregate at the cell membrane (Jeffrey et al., 2011) . In further contrast, sheep experimentally infected with the bovine spongiform encephalopathy (BSE) agent display conspicuous intra-and extracellular PrP d deposits (González et al., 2005a 
RESULTS

Correlation between BCTs
For the 40 scrapie samples tested (see details in Methods), the three BCTs showed high correlation values, with Spearman r values of 0.70 for enzyme immunoassay (EIA) versus Western blot (WB), 0.72 for enzyme-linked immunosorbent assay (ELISA) versus WB and 0.72 for ELISA versus EIA (Fig. 1a) . The correlations were also high for BSE samples, with r values between 0.69 (EIA vs WB) and 0.95 (ELISA vs EIA) for ARQ/ARQ sheep samples and between 0.74 (ELISA vs EIA) and 0.92 (ELISA vs WB) for ARR/ARR sheep samples (Fig. 1b) . It is worth noting that ARR/ARR sheep BSE samples provided much lower values in all three BCTs than those from ARQ/ARQ sheep (Fig. 1b) .
When analysing the association between BCT results independently for each brain area examined ( Fig. 1 and details in Table S1 , available in JGV Online), scrapie samples provided significant correlation values between all three BCTs in the cerebral cortex (0.77-0.95) and in the cerebellum (0.76-0.95), only between EIA and ELISA in the corpus striatum (0.65) and no significant correlations in the obex (20.05-0.48). For ARQ/ARQ BSE samples, correlations between the three BCTs were significant in the cerebellum (0.78-0.93), and only between ELISA and EIA in the cerebral cortex (0.89) and in the corpus striatum (0.41-0.86). For the 33 BSE brain samples, the correlation obtained between IHC and BCTs was much lower than that observed for the scrapie samples (Table 1 The analysis of ARQ/ARQ BSE samples by brain area confirmed the overall analysis insofar as the STEL type was the one showing the highest correlation coefficients in all three brain areas, although these were only significant for ELISA and EIA in the cerebral cortex and for EIA in the cerebellum (Supplementary data). 
Correlation between IHC and BCTs
Correlation between laboratory test results and infectivity
DISCUSSION
A clear correlation between laboratory test results, that is levels of abnormal PrP detectable by different methods, and infectious titre, has not been demonstrated within this study. It is however true that, with the exception of WB, sheep brain samples containing higher levels of abnormal PrP tended to provide higher infectious titres, although the individual variability in laboratory test results made differences to be non-significant. In addition to the small sample size, a number of other considerations need to be made in order to discuss and interpret this somewhat poor correlation: the assessment of infectivity in TgshpXI mice was done at 100-fold dilutions, the highest being at 10 25 ; this created three problems that could have affected the discriminatory capability of the comparative analysis: (i) the bimodal rather than sequential distribution of infectious titres, which prevented the realization of correlation analyses, (ii) the close proximity (in some cases identity) of the titres of some samples, and (iii) the inability to calculate precise infectious titres in the two samples that resulted in 100 % attack rate at the highest dilution. However, despite the fact that the infectious titres obtained partitioned into two distinct groups [considered to be of statistically significant different infectivity since titres differed by more than 0.8 log units (Mould et al., 1967) ], no clear correlation was found with corresponding test results. Therefore, it is also likely that a more accurate calculation of titres would not have fundamentally changed their correlation with test results.
Because the selection of samples for the different analyses was done from archival material, the samples scored for PrP d by IHC were from one hemi-brain while those for biochemical analysis and bioassay were from the other hemi-brain. Although it is widely assumed that both infectivity and abnormal PrP accumulation in the brain occur symmetrically, specific and detailed studies to verify these assumptions have not been carried out to the best of our knowledge. It is therefore possible that some asymmetry in the distribution of PrP d or infectivity might have contributed to a lack of clear correlation between IHC and infectious titres and between IHC and BCTs. This caveat, however, should not apply to the comparison between BCT results and infectivity, as all were carried out on the same ipsi-lateral brain samples. As the correlation between these tests and infectious scores was even lower than between infectivity and total amount of PrP d detected by IHC, it appears unlikely that poor correlations can be attributed to variations between tissue samples. A possible explanation for the relatively discrepant results between infectivity and BCTs is that these tests, which detect either protease-resistant PrP fragments (ELISA and, particularly, WB) or abnormal PrP d in a particular state of aggregation (EIA), fail to detect, to a greater or lesser extent, infectious PrP conformers (if such are actually the infectious agent). The dissociation between infectivity and WB results argues for a separation between highly PKresistant forms of PrP and infectivity. This is in contrast with reports from early studies (McKinley et al., 1983) , but would be in agreement with others showing that partially disaggregated and PK-sensitive (Rohwer, 1991; Caughey et al., 1997) , non-fibrillar PrP particles (Silveira et al., 2005) are associated with increased infectivity in hamsters. Along similar lines would be the reports of some cases of sporadic Creutzfeldt-Jakob disease, in which most or all the diseaseassociated PrP is PK-sensitive (Safar et al., 2005; Gambetti et al., 2008; Head et al., 2009) . The better association between the ELISA (low PK concentration) or the EIA (no PK treatment) results and infectious titres would support the notion of infectivity being related with partially PK-sensitive, not highly aggregated forms of abnormal PrP. Furthermore, the fact that our IHC protocol did not use enzyme digestion and is able to detect a wider range of (Fig. 4f ) and BSE1 Cc (Fig. 4a)] , and vice-versa (Table 2) . Some unanticipated observations have arisen from the analyses of the laboratory test results. Firstly, correlations between BCT results appeared to be brain area-dependent, at least for scrapie, in which such correlations did not exist in samples of obex but were consistently significant in the cerebral cortex and cerebellum. Also, both for scrapie and BSE in ARQ/ARQ sheep, ELISA and EIA provided better correlation values between them than when compared to WB. This was not the case, however, for ARR/ARR BSE samples for which WB showed the highest correlations. Secondly, from the comparative analysis of IHC profiles and BCTs, it would appear that the different morphological types of PrP d that can be identified in the brains of sheep may have different biochemical properties, but that these are also brain area-and agent-dependent. Thus, in ARQ/ARQ BSE sheep, ASTR extracellular PrP d did not correlate with BCT results in any of the brain areas examined, while it did so in the cerebral cortex, and to a lesser extent in the cerebellum and corpus striatum, of scrapie-infected sheep. In contrast, in sheep of the same ARQ/ARQ genotype, STEL PrP d was the type that provided the highest and most consistent correlations across different brain areas regardless of the infectious agent. Taken together, these observations suggest different morphological and cell-associated PrP d types may have different molecular properties in terms of aggregation states or resistance to protease treatment and denaturation, but that these are also influenced by a complex combination of infectious agent, host genetics and brain topography. Since all brains examined in this study were from animals at clinical endpoint and since the different brain areas start accumulating PrP d /PrP res at different times after infection [obex, cerebellum, corpus striatum and cerebral cortex from earliest to latest (Sisó et al., 2009) The high correlation found between the three BCTs employed is not surprising; these tests had been previously evaluated in a European Food Safety Authority trial and two of them, the ELISA and the EIA, gave similar diagnostic and analytical sensitivity on small ruminant TSE samples (EFSA Panel on Biological Hazards, 2009). Moreover, the three BCTs were performed on identical tissue homogenates, which undoubtedly contributed to the high correlation of their results. Considering that two of them, ELISA and WB, use PK digestion, while EIA relies on a polyanionic ligandaffinity and detects aggregated PrP d , the high correlation between the three BCTs argues for an association between protease resistance and aggregation state. , titres between 6.5 and 6.7) or high (grey bars, n55, titres between 8.1 and ¢8.7). In the left column note that, except for WB, samples with high infectious scores tend to provide higher laboratory test results; however, individual variability, particularly for the BCTs, makes differences not to be statistically significant. Similarly in the right column, where high infectious titre tends to correlate with higher IHC scores of different PrP d types; however, the only significant difference (P,0.05) is for the stellate (STEL) PrP d type. ITCL, Intracellular; ASTR, extracellular astrocyte-associated; NRPL, extracellular in neuropil.
within the context of the TSE sources and host PRNP genotypes used in this study -it does not necessarily reflect the extent of replication of the infectious agent, so that infectious titres cannot be predicted from laboratory test results. (Jeffrey et al., 2001b; González et al., 2002 González et al., , 2010b González et al., , 2012 Sisó et al., 2010) 2 and 1.0, respectively) and low infectivity (log titres of 6.5 and 6.7, respectively); (b) (BSE1 St) and (d) (BSE6 Cc) show moderate/high PrP d levels (9.5 and 10.4, respectively) and high infectious titres (log titre ¢8.7 in both cases). Other samples, however, do not show such correlation: (e) (BSE3 Ob) and (f) (Scra3 Cc) show similar PrP d magnitudes (9.1 and 9.7, respectively) to samples illustrated in (b) and (d) but their infectivity is low (log titre56.7 in both cases); despite identical infectious titre, note also the difference in intraneuronal PrP d , which is notably more prominent in BSE3 Ob (e) than in Scra3 Cc (f; for values refer to Table 2 ). IHC with R145 PrP antibody; magnifications:
(except for obex, which was not available for the seven BSE-affected ARQ/ ARQ sheep) were kept frozen at 280 uC for BCT analyses. Therefore, a total of 73 brain samples, 40 from scrapie-and 33 from BSE-affected sheep, were available for comparison between IHC features and BCT results.
Eleven of the 73 brain samples, three from scrapie and eight from BSE-affected sheep, were selected for bioassay in TgshpXI transgenic mice, which overexpress ovine ARQ/ARQ PrP (Kupfer et al., 2007) . The selection of the samples was made on the basis of differences in magnitude of PrP d accumulation observed by IHC (scores from 1.0 to 16.7) and/or in the proportion of different morphological and cellassociated PrP d types.
IHC and BCT in sheep brain samples. The processing of brain samples for IHC, which was performed with PrP antibody R145 (AHVLA), and the scoring system for quantification of PrP d accumulation have been described in detail previously (González et al., 2002 (González et al., , 2005a . Briefly, the magnitude of different types of disease-associated (PrP d ) aggregates was scored from 0 to 3 in the 73 samples included in this study. To facilitate comparisons with BCT and infectivity titration results, the PrP d types were grouped as follows: (i) intracellular (ITCL): intra-neuronal, intra-microglial and intraastrocytic, for a maximum score of 9; (ii) stellate (STEL) for a maximum score of 3; (iii) astrocyte-associated (ASTR): subpial, perivascular, subependymal and peri-vacuolar, for a maximum score of 12; (iv) grey matter neuropil-associated (NRPL): particulate/ coalescing, linear and peri-neuronal, for a maximum score of 9. The only other type of PrP d observed in the samples examined were non-vascular plaques, exclusively found in the three BSE-infected ARR/ARR sheep; this type is not considered in the analyses of individual PrP d types but was included in the score for total PrP d in each sample, which was worked out as the sum of scores of the different types considered (maximum theoretical score of 36). Since the IHC protocol did not include a protease-treatment step, PrP d is putatively composed of both protease-resistant and protease-sensitive forms of abnormal, disease-associated PrP (González et al., 2005b) .
Three BCTs were applied to the 73 selected brain samples. Two of the tests, the TeSeE 'sheep and goat' (Bio-Rad) and the Bio-Rad TeSeE 'sheep and goat' Western blot analysis (WB), are based on immunoaffinity and relative PK resistance at two different PK concentrations (fivefold lower in the ELISA than in the WB), thus detecting PrP res . The other, IDEXX HerdChek BSE/scrapie enzyme immunoassay (EIA; Idexx Laboratories), is a polyanionic ligandaffinity based method and does not require PK treatment, thus detecting PrP d . All three BCTs enable quantification of the abnormal PrP in the samples by means of end-point dilution assays, the results of which were used for comparison with the IHC scores and the titration results in the bioassay. Dilution curves for each sample were achieved by serially diluting samples 1 : 2 to give a dilution range from neat to 1 : 32 768. ELISA and WB samples were diluted post-extraction using sample diluent (R6) and Laemmli solution, respectively and then analysed according to manufacturer's instructions. EIA samples were diluted using de-ionized water prior to the addition of working plate diluent; once diluted all were analysed following manufacturer's instructions with diluted samples treated exactly the same as neat samples. We had previously shown that there were no noticeable differences between EIA dilution curves prepared using negative control brain homogenate [25 % (w/v) in kit homogenization buffer] and water (data not shown). End-point dilutions were given as the dilution at which the absorbance reading for the test sample was the same as that for the test kit negative control (ELISA and EIA) or the last dilution at which PrP res bands were observed (WB).
Bioassay in TgshpXI mice. Groups of 10 TgshpXI mice were each inoculated intracerebrally with 10
21
, 10 23 and 10 25 dilutions of each of the selected 11 sheep brain samples. This transgenic mouse line was selected because of Prnp genotypic homology with most of the samples inoculated; conventional wild-type mice were disregarded in view of previous evidence of inefficient transmissibility of scrapie isolates from the MRI Suffolk flock to such mice (Bruce et al., 2002) . Mice reaching clinical end-point of neurological disease compatible with scrapie/BSE, and those showing significant mobility deterioration or inability to eat or drink, were euthanized with carbon dioxide. Brains were removed and placed in buffered formalin and confirmation of scrapie/BSE was carried out by IHC for PrP d with rabbit polyclonal R486, which recognizes amino acid sequence 221-233 of bovine PrP, by procedures described elsewhere (Beck et al., 2010) . All mouse procedures were performed in compliance with the Animal (Experimental Procedures) Act 1986 under licence no. 70/6310 issued by the UK Home Office and were approved by the local ethics committee.
Infectious titres (LD 50 ) were determined by the Spearman-Karber formula (Hamilton et al., 1977) : log 10 LD 50 5(X 0 2[d/2])+d(Sr i /n i ), where for this case:
X 0 5log 10 of the lowest dilution at which all mice died of scrapie or BSE d5dilution factor r i 5number of positive mice in the X 0 and subsequent dilutions n i 5number of mice inoculated in the X 0 and subsequent dilutions (discounting those dying from intercurrent deaths) Since 20 ml of inocula were used for the intracerebral inoculations and the LD 50 is expressed by gram of tissue, a conversion factor of 6500 was applied to the titres obtained.
Statistical analyses. The relationship between the results of the three BCTs on individual samples (end-point dilution values) was assessed by means of Spearman's non-parametric correlation analyses (Instat GraphPad Software). The same approach was used to compare between individual sample results in IHC and in each of the three BCTs. These analyses were done for the total number of samples (n540 in scrapie, n521 in ARQ/ARQ BSE and n512 in ARR/ARR BSE samples) regardless of brain area of provenance, and also for each individual area separately. The latest were not performed on ARR/ ARR BSE samples due to the low number of sheep involved (n53).
The relationship between infectivity and laboratory test results was assessed by Mann-Whitney non-parametric analysis applied to samples grouped according to their titre. This strategy was necessary in view of the bi-modal distribution of the infectious titres obtained in the 11 samples selected for bioassay.
